TLR2 and myeloid sarcoma: The glycosaminoglycan hyaluronan was also identified in MS lesions (Back et al., 2005) and was found to be an inhibitor of OPC maturation and remyelination through Toll-like receptor 2 (TLR2; Sloane et al., 2010).